NEM
59
2
FOX
73
3
GRMN
55
7
LH
45
2
CNX
48
2
EIX
29
2
CNP
57
3
UNP
48
5
JCI
45
3
PH
59
2
FCX
43
3
ICE
48
2
CPB
24
2
CSCO
66
6
KMI
71
4
EMC
33
6
IP
53
5
LNC
30
4
PNC
53
5
MTB
49
5
NEM
59
2
FOX
73
3
GRMN
55
7
LH
45
2
CNX
48
2
EIX
29
2
CNP
57
3
UNP
48
5
JCI
45
3
PH
59
2
FCX
43
3
ICE
48
2
CPB
24
2
CSCO
66
6
KMI
71
4
EMC
33
6
IP
53
5
LNC
30
4
PNC
53
5
MTB
49
5
Financhill
Back

Triumph Financial Vs. Summit Therapeutics Industry Stock Comparison

Sell
28

TFIN
Triumph Financial

Last Price:
$87.23
Seasonality Move:
2.72%
Sell
29

SMMT
Summit Therapeutics

Last Price:
$16.66
Seasonality Move:
7.78%
Sell
28
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $87.25. The Score for TFIN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $16.65. The Score for SMMT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $87.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $16.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.27 Sell
Relative Strength Index (14 RSI): 38.93 Sell
Chaikin Money Flow: 54992 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.18 - 98.8) Sell
Bollinger Bands (100): (79.75 - 98.75) Sell

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 40.61 Sell
Chaikin Money Flow: -2642249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.6 - 18.78) Sell
Bollinger Bands (100): (15.7 - 22.62) Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.95 Buy
20-day SMA: 90.75 Sell
50-day SMA: 96.57 Sell
200-day SMA: 83.83 Buy
8-day EMA: 87.21 Buy
20-day EMA: 90.59 Sell
50-day EMA: 92.7 Sell
200-day EMA: 85.4 Buy

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.96 Sell
20-day SMA: 18.15 Sell
50-day SMA: 18.76 Sell
200-day SMA: 13.03 Buy
8-day EMA: 17.83 Sell
20-day EMA: 18.12 Sell
50-day EMA: 18.46 Sell
200-day EMA: 14.25 Buy

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $1.22 per share.

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):